Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [12]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ALX-804-624-C100 - Provider product page
- Provider
- Enzo Life Sciences
- Proper citation
- Enzo Life Sciences Cat#ALX-804-624-C100, RRID:AB_2051325
- Product name
- Doxorubicin, mAb (MAD11)
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Liquid. Purified antibody containing 150mM sodium chloride and 0.02% sodium azide, pH 7.4.
- Isotype
- IgG
- Antibody clone number
- MAD11
Submitted references Role of proliferation in HER2 status predicted response to doxorubicin.
Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice.
Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.
Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats.
Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice.
Effect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice.
Relevance of antibody valency in EGF receptor modulation.
Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies.
An anti-doxorubicin monoclonal antibody modulates kinetic and dynamic characteristics of the drug.
Anti-drug monoclonal antibodies antagonize toxic effect more than anti-tumor activity of doxorubicin.
A new monoclonal antibody recognizing anthracyclinic molecule.
Monoclonal antibodies against doxorubicin.
Campiglio M, Somenzi G, Olgiati C, Beretta G, Balsari A, Zaffaroni N, Valagussa P, Ménard S
International journal of cancer 2003 Jul 1;105(4):568-73
International journal of cancer 2003 Jul 1;105(4):568-73
Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice.
Balsari A, Rumio C, Morelli D, Sfondrini L, Nardini E, Barajon I, Ménard S
British journal of cancer 2001 Dec 14;85(12):1964-7
British journal of cancer 2001 Dec 14;85(12):1964-7
Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.
Morelli D, Ménard S, Cazzaniga S, Colnaghi MI, Balsari A
British journal of cancer 1997;75(5):656-9
British journal of cancer 1997;75(5):656-9
Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats.
Cece R, Cazzaniga S, Morelli D, Sfondrini L, Bignotto M, Ménard S, Colnaghi MI, Balsari A
Laboratory investigation; a journal of technical methods and pathology 1996 Oct;75(4):601-9
Laboratory investigation; a journal of technical methods and pathology 1996 Oct;75(4):601-9
Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice.
Morelli D, Ménard S, Colnaghi MI, Balsari A
Cancer research 1996 May 1;56(9):2082-5
Cancer research 1996 May 1;56(9):2082-5
Effect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice.
Morelli D, Ménard S, Pozzi B, Balsari A, Colnaghi MI
Cell biophysics 1994;24-25:119-26
Cell biophysics 1994;24-25:119-26
Relevance of antibody valency in EGF receptor modulation.
Morelli D, Villa E, Tagliabue E, Perletti L, Villa ML, Ménard S, Balsari A, Colnaghi MI
Scandinavian journal of immunology 1994 May;39(5):453-8
Scandinavian journal of immunology 1994 May;39(5):453-8
Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies.
Balsari AL, Morelli D, Ménard S, Veronesi U, Colnaghi MI
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1994 Feb;8(2):226-30
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1994 Feb;8(2):226-30
An anti-doxorubicin monoclonal antibody modulates kinetic and dynamic characteristics of the drug.
Sardini A, Villa E, Morelli D, Ghione M, Ménard S, Colnaghi MI, Balsari A
International journal of cancer 1992 Feb 20;50(4):617-20
International journal of cancer 1992 Feb 20;50(4):617-20
Anti-drug monoclonal antibodies antagonize toxic effect more than anti-tumor activity of doxorubicin.
Balsari A, Ménard S, Colnaghi MI, Ghione M
International journal of cancer 1991 Apr 1;47(6):889-92
International journal of cancer 1991 Apr 1;47(6):889-92
A new monoclonal antibody recognizing anthracyclinic molecule.
Balsari A, Morelli D, Menard S, Tagliabue E, Colnaghi MI, Ghione M
Anticancer research 1990 Jan-Feb;10(1):129-32
Anticancer research 1990 Jan-Feb;10(1):129-32
Monoclonal antibodies against doxorubicin.
Balsari A, Alzani R, Parrello D, Morelli D, Tagliabue E, Gianni L, Isetta AM, Menard S, Colnaghi MI, Ghione M
International journal of cancer 1988 Nov 15;42(5):798-802
International journal of cancer 1988 Nov 15;42(5):798-802
No comments: Submit comment
No validations: Submit validation data